Latent tuberculosis in healthcare workers: Time to act

Oman Medical Journal

Volumn 28, Issue 2, 2013, Pages 146-148

  Al Jahdhami, Issa ^a  

^a Armed Forces Hospital   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ARTICLE; DISEASE COURSE; HEALTH CARE PERSONNEL; HUMAN; INFECTION RISK; LATENT TUBERCULOSIS; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NURSE; PHYSICIAN; PREDICTIVE VALUE; PREVALENCE; PROPHYLAXIS; RISK BENEFIT ANALYSIS; RISK FACTOR; T LYMPHOCYTE; THORAX RADIOGRAPHY; TUBERCULIN TEST;

EID: 84875955932     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2013.39     Document Type: Article

References (24)

1. Al-Maniri A, Al-Rawas O, Al-Tuhami H, Eriksson B, Diwan VK. Towards the elimination of tuberculosis in a developing country: 25 years of tuberculosis control in Oman. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2007; 11:175-180.
2. Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011 Jun;11(6):435-444.
3. Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 2011 Apr;364(15):1441-1448.
4. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000 Apr;161(4 Pt 2):S221-S247.
5. de Vries G, Sebek MM, Lambregts-van Weezenbeek CS. Healthcare workers with tuberculosis infected during work. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 2006; 28:1216-1221.
6. Severo KG, Oliveira JdaS, Carneiro M, Valim AR, Krummenauer EC, Possuelo LG. Latent tuberculosis in nursing professionals of a Brazilian hospital. J Occup Med Toxicol 2011;6(1):15.
7. Al-Maniri A, Fochsen G, Al-Rawas O, De Costa A. Immigrants and health system challenges to TB control in Oman. BMC Health Serv Res 2010;10:210.
8. Demkow U, Broniarek-Samson B, Filewska M, Lewandowska K, Maciejewski J, Zycinska K, et al. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests. Journal of physiology and pharmacology: an official journal of the Polish Physiological Society 2008; 59 Suppl 6:209-217.
9. Sawanyawisuth K, Chaiear N, Sawanyawisuth K, Limpawattana P, Bourpoern J, Reechaipichitkul W, et al. Can workplaces be predictors for recent onset latent tuberculosis in health care workers? J Occup Med Toxicol 2009;4:20.
10. Mirtskhulava V, Kempker R, Shields KL, Leonard MK, Tsertsvadze T, del Rio C, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2008;12:513-519.
11. Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, et al. Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One 2009;4(8):e6686.
12. He GX, van denHof S, van der Werf MJ, Wang GJ, Ma SW, Zhao DY, et al. Infection control and the burden of tuberculosis infection and disease in health care workers in china: a cross-sectional study. BMC Infect Dis 2010;10:313.
13. Ringshausen FC, Schlösser S, Nienhaus A, Schablon A, Schultze-Werninghaus G, Rohde G. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. J Occup Med Toxicol 2009;4:11.
14. Tripodi D, Brunet-Courtois B, Nael V, Audrain M, Chailleux E, Germaud P, et al. Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers. J Occup Med Toxicol 2009;4:30.
15. Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A. Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases. J Occup Med Toxicol 2009;4:1.
16. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 2011; 37:88-99.
17. Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010;10:57.
18. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008 May;177(10):1164-1170.
19. Lee SW, Oh DK, Lee SH, Kang HY, Lee CT, Yim JJ. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 2011; 37:1447-1452.
20. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012 Jan;67(1):62-70.
21. Abdalhamid B, Hinrichs SH, Garrett JL, O'Neill JM, Hansen-Cain KM, Armbrust AA, et al. Utilization of the QuantiFERON-TB Gold test in a twostep process with the tuberculin skin test to evaluate health care workers for latent tuberculosis. J Clin Microbiol 2010 Aug;48(8):2955-2956.
22. Torres Costa J, Silva R, Sá R, Cardoso MJ, Nienhaus A. Results of five-year systematic screening for latent tuberculosis infection in healthcare workers in Portugal. J Occup Med Toxicol 2010;5:22.
23. Ibrahim Abubakar CB, Steve Bradley, Ann Chapman, Timothy Collyns, Francis Drobniewki. NICE clinical guidline 117 Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2011.
24. Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al; TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011 Dec;365(23):2155-2166.